bioAffinity Technologies, Inc.
BIAF • NASDAQ
bioAffinity Technologies, Inc. is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Maria Zannes, with a market cap of $14.9M.
Market Cap$14.9M
Employees75.0
CEOMaria Zannes
CountryUnited States of America
Healthcare
Medical - Diagnostics & Research
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
bioAffinity Technologies, Inc. FAQ
Common questions about bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. is scheduled to report earnings for Q1 2026 on May 14, 2026. Analysts estimate revenue of $1.5M.
bioAffinity Technologies, Inc. has approximately 75 employees.